Objective: To assess performance of TIRADS classification on a prospective surgical cohort, demonstrating its clinical usefulness.
Methods: Between June 2009 and October 2012, patients assessed with pre-operative ultrasound (US) were included in this IRB-approved study. Nodules were categorised according to our previously described TIRADS classification. Final pathological diagnosis was obtained from the thyroidectomy specimen. Sensitivity, specificity, positive/negative predictive values and likelihood ratios were calculated.
Results: The study included 210 patients with 502 nodules (average: 2.39 (±1.64) nodules/patient). Median size was 7 mm (3-60 mm). Malignancy was 0 % (0/116) in TIRADS 2, 1.79 % (1/56) in TIRADS 3, 76.13 % (185/243) in TIRADS 4 [subgroups: TIRADS 4A 5.88 % (1/17), TIRADS 4B 62.82 % (49/78), TIRADS 4C 91.22 % (135/148)], and 98.85 % (86/87) in TIRADS 5. With a cut-off point at TIRADS 4-5 to perform FNAB, we obtained: sensitivity 99.6 % (95 % CI: 98.9-100.0), specificity 74.35 % (95 % CI: 68.7-80.0), PPV 82.1 % (95 % CI: 78.0-86.3), NPV 99.4 % (95 % CI: 98.3-100.0), PLR 3.9 (95 % CI: 3.6-4.2) and an NLR 0.005 (95 % CI: 0.003-0.04) for malignancy.
Conclusion: US-based TIRADS classification allows selection of nodules requiring FNAB and recognition of those with a low malignancy risk.
Key Points: • TIRADS classification allows accurate selection of thyroid nodules requiring biopsy (TIRADS 4-5). • The recognition of benign/possibly benign patterns can avoid unnecessary procedures. • This classification and its sonographic patterns are validated using surgical specimens.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00330-016-4605-y | DOI Listing |
J Endocrinol Invest
December 2024
Clinic for Radiology, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.
Objectives: Ultrasound (US) evaluation is recognized as pivotal in assessing the risk of malignancy (RoM) of thyroid nodules (TNs). Recently, various US-based risk-classification systems (Thyroid Imaging and Reporting Data Systems [TIRADSs] have been developed. An important ongoing project concerns the creation of an international system (I-TIRADS) using unique terminology.
View Article and Find Full Text PDFKhirurgiia (Mosk)
December 2024
Petrovsky National Research Center of Surgery, Moscow, Russia.
Objective: To analyze the efficacy of the S-Detect AI system of the Samsung RS85 ultrasound scanner (South Korea) in stratifying thyroid nodules compared to data obtained by specialist of ultrasound diagnostics.
Material And Methods: In 2024, we analyzed ultrasound data of 80 patients with thyroid nodules who required fine-needle aspiration biopsy (FNAB). Patients underwent thyroid ultrasound with nodule assessment according to the EU TI-RADS classification (GE Voluson E8 scanner, USA).
Semergen
December 2024
Medicina Familiar y Comunitaria, Centro de Salud Don Benito Oeste, Don Benito, Badajoz; Miembro del Grupo de Trabajo de Ecografía de SEMERGEN, España.
The thyroid nodule is a frequent lesion within the thyroid. Its incidence is between 50%-60% and most of them are asymptomatic and benign (90-95%) and its diagnosis is frequently made as an incidental finding. The main objective of their study is to rule out thyroid cancer.
View Article and Find Full Text PDFClin Radiol
November 2024
Department of Radiology, Queen Alexandra Hospital, Portsmouth, UK.
Aim: The British Thyroid Association (BTA) Guidelines for the Management of Thyroid Cancer advocate for fine-needle aspiration cytology for all thyroid nodules graded indeterminate (U3) at ultrasound assessment. This approach raises concerns regarding potential over-diagnosis of low-risk lesions. Conversely, equivalent Thyroid Imaging Reporting and Data Systems (TIRADS) guidelines permit surveillance or discharge of indeterminate thyroid nodules of certain sizes.
View Article and Find Full Text PDFClin Radiol
November 2024
Imperial College Healthcare NHS Trust, UK. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!